サンプル依頼リスト カート
  • English
  • Korean
表紙：組織工学・再生の世界市場規模調査＆予測：製品別、用途別、地域別分析、2023-2030年
市場調査レポート
商品コード
1303553

組織工学・再生の世界市場規模調査＆予測：製品別、用途別、地域別分析、2023-2030年

Global Tissue Engineering and Regeneration Market Size study & Forecast, by Product (Biomaterials, Cell Therapy, Tissue Engineering), by Application (Orthopedics, Dermatology, Cardiology, Neurology, Others) and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
組織工学・再生の世界市場規模調査＆予測：製品別、用途別、地域別分析、2023-2030年
出版日: 2023年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の組織工学・再生市場は、人体の損傷・疾病した組織や臓器の修復・修復・置換のために、工学的・生物学的原理を応用して新たな組織や臓器を開拓・製造する医療産業の一分野です。

組織工学・再生の分野には、生体材料、幹細胞治療、遺伝子治療、3Dプリンティングなど、さまざまな技術が含まれます。組織工学・再生の世界市場の主な促進要因は、慢性疾患の有病率の増加と老人人口の増加です。さらに、臓器移植の需要の増加と研究開発活動の活発化が、予測期間2023-2030年にかけて市場に有利な成長機会を生み出しています。

組織工学・再生の分野における研究開発活動への多額の投資が、この市場の成長を促進しています。2021年、ミネソタ大学の研究者は、神経細胞の成長を促進することで脊髄損傷の修復に役立つ3Dプリンテッド足場を開発しました。同様に2020年には、ハーバード大学のWyss Institute for Biologically Inspired Engineeringの研究者が、ヒト幹細胞から機能的な肝細胞を大量に増殖させる新しい方法を開発しました。さらに2021年には、ノースウェスタン大学の科学者が、心臓発作で損傷した心臓組織の修復に役立つ新しいタイプのハイドロゲルを開発しました。しかし、組織工学・再生には高いコストがかかるため、2023～2030年の予測期間を通じて市場の成長は阻害されます。

組織工学・再生の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、組織工学・再生において圧倒的なシェアを占める地域です。これは、この地域に複数の主要企業が存在すること、研究開発活動が活発化していること、臨床試験が数多く実施されていることに起因しています。アジア太平洋地域は、研究開発活動への投資が増加していること、患者数が多いこと、再生医療に対する意識が高まっていることから、組織工学・再生市場で最も速い成長が見込まれています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 組織工学・再生市場：地域別、2020～2030年
    • 組織工学・再生市場：製品別、2020～2030年
    • 組織工学・再生市場：用途別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 組織工学・再生の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 組織工学・再生の世界市場力学

  • 組織工学・再生市場の影響分析（2020～2030年）
    • 市場促進要因
      • 慢性疾患の増加
      • 老年人口の増加
    • 市場の課題
      • 組織工学・再生の高コスト
    • 市場機会
      • 臓器移植需要の増加
      • 研究開発活動の増加

第4章 世界の組織工学・再生市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 組織工学・再生の世界市場：製品別

  • 市場スナップショット
  • 組織工学・再生の世界市場：製品別、実績、潜在能力分析
  • 組織工学・再生の世界市場：製品別推定・予測、2020～2030年
  • 組織工学・再生市場のサブセグメント分析
    • バイオマテリアル
    • 細胞治療
    • 組織工学

第6章 組織工学・再生の世界市場：用途別

  • 市場スナップショット
  • 組織工学・再生の世界市場：用途別実績-潜在能力分析
  • 組織工学・再生の世界市場：用途別推定・予測、2020-2030年
  • 組織工学・再生市場のサブセグメント分析
    • 整形外科学
    • 皮膚科学
    • 心臓学
    • 神経学
    • その他

第7章 組織工学・再生の世界市場、地域分析

  • 主要国
  • 主な新興国
  • 組織工学・再生市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品の推定・予測、2020-2030年
      • 用途の推定・予測、2020-2030年
    • カナダ
  • 欧州の組織工学・再生市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の組織工学・再生市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの組織工学・再生市場のスナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Organogenesis Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Acelity L.P. Inc.
    • Zimmer Biomet Holdings Inc.
    • Stryker Corporation
    • Integra LifeSciences Holdings Corporation
    • Medtronic plc
    • Smith & Nephew plc
    • Athersys Inc.
    • Vericel Corporation
    • Osiris Therapeutics, Inc.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Tissue Engineering and Regeneration Market, report scope
  • TABLE 2. Global Tissue Engineering and Regeneration Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Tissue Engineering and Regeneration Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Tissue Engineering and Regeneration Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Tissue Engineering and Regeneration Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Tissue Engineering and Regeneration Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Tissue Engineering and Regeneration Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Tissue Engineering and Regeneration Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Tissue Engineering and Regeneration Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Tissue Engineering and Regeneration Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Tissue Engineering and Regeneration Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Tissue Engineering and Regeneration Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Tissue Engineering and Regeneration Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Tissue Engineering and Regeneration Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Tissue Engineering and Regeneration Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Tissue Engineering and Regeneration Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Tissue Engineering and Regeneration Market
  • TABLE 70. List of primary sources, used in the study of global Tissue Engineering and Regeneration Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Tissue Engineering and Regeneration Market, research methodology
  • FIG 2. Global Tissue Engineering and Regeneration Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Tissue Engineering and Regeneration Market, key trends 2022
  • FIG 5. Global Tissue Engineering and Regeneration Market, growth prospects 2023-2030
  • FIG 6. Global Tissue Engineering and Regeneration Market, porters 5 force model
  • FIG 7. Global Tissue Engineering and Regeneration Market, pest analysis
  • FIG 8. Global Tissue Engineering and Regeneration Market, value chain analysis
  • FIG 9. Global Tissue Engineering and Regeneration Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Tissue Engineering and Regeneration Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Tissue Engineering and Regeneration Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Tissue Engineering and Regeneration Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Tissue Engineering and Regeneration Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Tissue Engineering and Regeneration Market, regional snapshot 2020 & 2030
  • FIG 15. North America Tissue Engineering and Regeneration Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Tissue Engineering and Regeneration Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia Pacific Tissue Engineering and Regeneration Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Tissue Engineering and Regeneration Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Tissue Engineering and Regeneration Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Tissue Engineering and Regeneration Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. The global tissue engineering and regeneration market is a segment of the medical industry that involves the application of engineering and biological principles to develop and manufacture new tissues and organs for the repair, restoration, or replacement of damaged or diseased tissues and organs in the human body. The field of tissue engineering and regeneration encompasses a range of technologies, including biomaterials, stem cell therapy, gene therapy, and 3D printing, among others. The major driving factors for the Global Tissue Engineering and Regeneration Market are increasing prevalence of chronic diseases and growing geriatric population. Moreover, growing demand for organ transplantation and increasing research and development activities are creating lucrative growth opportunities for the market over the forecast period 2023-2030.

Significant investments in research and development activities in the field of tissue engineering and regeneration are driving the growth of this market. In 2021, researchers from the University of Minnesota developed a 3D-printed scaffold that can help repair spinal cord injuries by promoting the growth of nerve cells. Similarly, in 2020, researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University developed a new method for growing large quantities of functional liver cells from human stem cells. Additionally, in 2021, scientists from Northwestern University developed a new type of hydrogel that can help repair heart tissue damaged by a heart attack. However, the high cost of Tissue Engineering and Regeneration stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Tissue Engineering and Regeneration Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the dominating region for tissue engineering and regeneration, accounting for the highest share of the market. This can be attributed to the presence of several key players in the region, increasing R&D activities, and a large number of clinical trials being conducted. The Asia Pacific region is expected to witness the fastest growth in the tissue engineering and regeneration market due to increasing investments in research and development activities, a large patient pool, and growing awareness about regenerative medicine.

Major market players included in this report are:

  • Organogenesis Inc.
  • Acelity L.P. Inc.
  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Smith & Nephew plc
  • Athersys Inc.
  • Vericel Corporation
  • Osiris Therapeutics, Inc.

Recent Developments in the Market:

  • In 2020, Organogenesis announced the launch of its PuraPly Antimicrobial Wound Matrix, a product designed to reduce bacterial contamination and support the healing of chronic wounds. In 2021, the company acquired NuTech Medical, a developer of advanced wound care products.
  • In 2020, Acelity launched its PREVENA RESTOR AXIO*FORM Incision Management System, a product designed to promote healing and prevent infection following breast reconstruction surgery. In 2021, the company announced the acquisition of Crawford Healthcare, a UK-based wound care and dermatology company.

Global Tissue Engineering and Regeneration Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Biomaterials
  • Cell Therapy
  • Tissue Engineering

By Application:

  • Orthopedics
  • Dermatology
  • Cardiology
  • Neurology
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Tissue Engineering and Regeneration Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Tissue Engineering and Regeneration Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Tissue Engineering and Regeneration Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Tissue Engineering and Regeneration Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Tissue Engineering and Regeneration Market Dynamics

  • 3.1. Tissue Engineering and Regeneration Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Tissue Engineering and Regeneration
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing demand for organ transplantation
      • 3.1.3.2. Increasing research and development activities

Chapter 4. Global Tissue Engineering and Regeneration Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Tissue Engineering and Regeneration Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Tissue Engineering and Regeneration Market by Product, Performance - Potential Analysis
  • 5.3. Global Tissue Engineering and Regeneration Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Tissue Engineering and Regeneration Market, Sub Segment Analysis
    • 5.4.1. Biomaterials
    • 5.4.2. Cell Therapy
    • 5.4.3. Tissue Engineering

Chapter 6. Global Tissue Engineering and Regeneration Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Tissue Engineering and Regeneration Market by Application, Performance - Potential Analysis
  • 6.3. Global Tissue Engineering and Regeneration Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Tissue Engineering and Regeneration Market, Sub Segment Analysis
    • 6.4.1. Orthopedics
    • 6.4.2. Dermatology
    • 6.4.3. Cardiology
    • 6.4.4. Neurology
    • 6.4.5. Others

Chapter 7. Global Tissue Engineering and Regeneration Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Tissue Engineering and Regeneration Market, Regional Market Snapshot
  • 7.4. North America Tissue Engineering and Regeneration Market
    • 7.4.1. U.S. Tissue Engineering and Regeneration Market
      • 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Tissue Engineering and Regeneration Market
  • 7.5. Europe Tissue Engineering and Regeneration Market Snapshot
    • 7.5.1. U.K. Tissue Engineering and Regeneration Market
    • 7.5.2. Germany Tissue Engineering and Regeneration Market
    • 7.5.3. France Tissue Engineering and Regeneration Market
    • 7.5.4. Spain Tissue Engineering and Regeneration Market
    • 7.5.5. Italy Tissue Engineering and Regeneration Market
    • 7.5.6. Rest of Europe Tissue Engineering and Regeneration Market
  • 7.6. Asia-Pacific Tissue Engineering and Regeneration Market Snapshot
    • 7.6.1. China Tissue Engineering and Regeneration Market
    • 7.6.2. India Tissue Engineering and Regeneration Market
    • 7.6.3. Japan Tissue Engineering and Regeneration Market
    • 7.6.4. Australia Tissue Engineering and Regeneration Market
    • 7.6.5. South Korea Tissue Engineering and Regeneration Market
    • 7.6.6. Rest of Asia Pacific Tissue Engineering and Regeneration Market
  • 7.7. Latin America Tissue Engineering and Regeneration Market Snapshot
    • 7.7.1. Brazil Tissue Engineering and Regeneration Market
    • 7.7.2. Mexico Tissue Engineering and Regeneration Market
  • 7.8. Middle East & Africa Tissue Engineering and Regeneration Market
    • 7.8.1. Saudi Arabia Tissue Engineering and Regeneration Market
    • 7.8.2. South Africa Tissue Engineering and Regeneration Market
    • 7.8.3. Rest of Middle East & Africa Tissue Engineering and Regeneration Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Organogenesis Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Acelity L.P. Inc.
    • 8.3.3. Zimmer Biomet Holdings Inc.
    • 8.3.4. Stryker Corporation
    • 8.3.5. Integra LifeSciences Holdings Corporation
    • 8.3.6. Medtronic plc
    • 8.3.7. Smith & Nephew plc
    • 8.3.8. Athersys Inc.
    • 8.3.9. Vericel Corporation
    • 8.3.10. Osiris Therapeutics, Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption